The Lupus Forum

The Lupus Forum
  • 0,0 (0)
  • EDUCAÇÃO
  • MENSAL
The Lupus Forum

Welcome to the Lupus Forum. The Lupus Forum is an educational website developed under the auspices of the University of Leeds and is dedicated to the dissemination of the latest developments in the field of lupus. It provides continuing medical education to clinicians around the globe to facilitate greater understanding of lupus, its treatments, and clinical practice.

  1. Lupus at ACR 2024: Preview Podcast

    12 DE NOV.

    Lupus at ACR 2024: Preview Podcast

    Lupus at ACR 2024: Preview Podcast by The Lupus Forum

    17min
  2. ACR 2024 Highlights: Day 1

    11 DE NOV.

    ACR 2024 Highlights: Day 1

    ACR 2024 Highlights: Day 1 by The Lupus Forum

    3min
  3. ACR 2024 Highlights: Day 2

    11 DE NOV.

    ACR 2024 Highlights: Day 2

    ACR 2024 Highlights: Day 2 by The Lupus Forum

    4min
  4. ACR 2024 Highlights: Day 3

    11 DE NOV.

    ACR 2024 Highlights: Day 3

    ACR 2024 Highlights: Day 3 by The Lupus Forum

    3min
  5. Discussing Lupus: Defining ANA-associated arthritis and achieving treatment targets

    31 DE OUT.

    Discussing Lupus: Defining ANA-associated arthritis and achieving treatment targets

    Steering Committee members Professor Ed Vital, who is a Professor in Autoimmune Connective Tissue Diseases and Honorary Consultant Rheumatologist, at Leeds Teaching Hospitals NHS Trust, UK, is joined by Professor Richard Furie, who is Chief of the Division of Rheumatology at the Department of Medicine, Northwell Health, New York, and Professor of Medicine at the Zucker School of Medicine at Hofstra/Northwell, and Professor Liz Lightstone, from the Imperial College Healthcare NHS Trust Renal and Transplant Centre, Hammersmith, London, on the latest Lupus Forum podcast. Together, they discuss defining ANA-associated arthritis and proposing new basket trial groupings, as well as evaluating the achievement of EULAR/ERA-EDTA treatment targets in lupus nephritis and the need for therapy adjustments. If you are interested in any of the papers discussed, head on over to the Lupus Forum today! Download our latest slide decks and stay up to date with our monthly podcasts, all through this free independent resource: https://lupus-forum.com/

    24min
  6. Discussing Lupus: Sequential belimumab and rituximab treatment and CAR T-cell therapy

    26 DE SET.

    Discussing Lupus: Sequential belimumab and rituximab treatment and CAR T-cell therapy

    Steering Committee members Professor Chris Edwards from the University Hospital Southampton NHS Foundation Trust is joined by Professor Victoria Werth, from the Philadelphia Veterans Administration Hospital, Pennsylvania, USA on the latest Lupus Forum podcast. Together, they discuss the efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with SLE, as well as CD19-CAR T-cell therapy inducing B cell deep tissue depletion! If you are interested in any of the papers discussed, head on over to the Lupus Forum today! Download our latest slide decks and stay up to date with our monthly podcasts, all through this free independent resource: https://lupus-forum.com/

    18min
  7. Rising to the challenge of inequity of outcomes in lupus treatment

    18 DE SET.

    Rising to the challenge of inequity of outcomes in lupus treatment

    Join Professors Ed Vital, Vibeke Strand, Laurent Arnaud, and Guillermo Pons-Estel as they unpack the key challenges of inequities of outcomes in lupus treatment. Providing an overview of social determinants of health in SLE, the impact of race and ancestry, and controlling disease in low and middle income country populations. You can view this video on our website here: https://lupus-forum.com/expert-live/4/rising-to-the-challenge-of-inequity-of-outcomes-in-lupus-treatment

    1h27min
  8. Discussing Lupus: Flare Prediction and CD163 in Lupus Nephritis

    29 DE AGO.

    Discussing Lupus: Flare Prediction and CD163 in Lupus Nephritis

    Lupus Forum Chair Ed Vital, from the University of Leeds, is joined by Doctor Antony Psarras, an NIHR Academic Clinical Lecturer in Rheumatology at the University of Oxford and at the Kennedy Institute of Rheumatology. Together, they discuss the use of CD163 as a marker for diagnosis and flare in lupus nephritis. They also discuss the impact of discontinuing immunosuppression on the disease, in particular looking at novel research surrounding the predictors of flares, time to withdrawal and long-term outcomes. If you are interested in any of the papers discussed, head on over to the Lupus Forum today! Download our latest slide decks and stay up to date with our monthly podcasts, all through this free independent resource: https://lupus-forum.com/

    24min
Ver tudo (49)

Sobre

Welcome to the Lupus Forum. The Lupus Forum is an educational website developed under the auspices of the University of Leeds and is dedicated to the dissemination of the latest developments in the field of lupus. It provides continuing medical education to clinicians around the globe to facilitate greater understanding of lupus, its treatments, and clinical practice.

Informações

  • Criado por
    The Lupus Forum
  • Anos de atividade
    2 mil
  • Episódios
    49
  • Classificação
    Livre
  • Copyright
    © All rights reserved
  • Site do podcast
    The Lupus Forum

Você também pode gostar de

Para ouvir episódios explícitos, inicie sessão.

Fique por dentro deste podcast

Inicie sessão ou crie uma conta para seguir podcasts, salvar episódios e receber as atualizações mais recentes.
Selecionar um país ou região

África, Oriente Médio e Índia

Ásia‑Pacífico

Europa

América Latina e Caribe

Estados Unidos e Canadá